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Abstract
Objective : To analyze the relationship between preeclampsia 
(PE) and the newborn hearing loss.
Methods : This cross-sectional study was conductedat RSMH 
Palembang since December 2016 to July 2017, obtained 48 
aterm neonates born from mother diagnosed with PE (11 
PE and 37 severe PE). Measurements of neonatal hearing 
loss then performed using emission otoacoustic (OAE) in 
both ears by ENT division with categories interpretation 
of pass and referred. The mothers were physically checked 
and interviewed to obtain demographic data and obstetric 
history. After the data normality were proved by Shapiro 
Wilk test, we performed bivariate analysis using X2 test on 
demographic and obstetric characteristics of the mother, 
neonatal demographic characteristics, and determine the 
relationship of PE with OAE result.
Results : There were no signifi cant differences in maternal 
and neonatal demographic characteristics in neonatal 
hearing loss (p> 0.05). No signifi cant relationship was found 
between PE and OAE of both ear (right, p = 0.437; left, p 
= 0.368). There was difference of mean of SBP and DBP 
of mother in neonate OAE of both ears (p <0.05) with cut 
offpoint of SBP 160 mmHg and DBP 106 mmHg.There was 
a signifi cant association between DBP (≥ 106 mmHg) of 
the mother and birth weight of the fetus (< 2.500 g) with 
referred OAE.
Conclusions : There was a signifi cant association between 
neonatal hearing loss and maternal PE, determined primarily 
by maternal DBP, and neonatal birth weight.
Keywords : maternal blood pressure, OAE, preeclampsia.
Abstrak
Tujuan : Untuk menilai hubungan preeklamsia (PE) ibu 
dengan penurunan pendengaran bayi baru lahir.
Metode : Penelitian observasi analitik dengan disain potong 
lintang dilakukan di RSMH Palembang sejak Desember 2016 
sampai Juli 2017, diperoleh 48 neonatus aterm lahir dari ibu 
PE (11 PER dan 37 PEB). Neonatus dilakukan pengukuran 
pendengaran menggunakan otoakustik emisi (OAE) pada 
kedua telinga oleh divisi THT dengan kategori intepretasi 
refer dan pass. Ibu dilakukan pemeriksaan dan wawancara 
untuk memperoleh data demografi  dan riwayat obstetri. 
Setelah normalitas data dibuktikan dengan tes Saphiro 
Wilk, dilakukan analisis bivariat menggunakan tes X2 pada 
karakteristik demografi  dan obstetri Ibu, karakteristik 
demografi  neonatus, dan menentukan hubungan PE dengan 
hasil OAE.
Hasil : Tidak ditemukan perbedaan signifi kan karakteristik 
demografi  Ibu maupun neonatus tehadap penurunan 
pendengaran neonatus (p>0,05). Tidak ditemukan hubungan 
signfi kan antara kondisi PE dengan OAE kanan (p = 0,437) 
dan kiri (p = 0,368). Ditemukan perbedaan rerata TDS dan 
TDD ibu terhadap OAE kedua telinga neonatus (p<0,05) 
dengan cut off point TDS 160 mmHg dan TDD 106 mmHg. 
Ditemukan hubungan signifi kan antara TDD (>106 mmHg) 
ibu dan berat lahir janin (>2500 gr) dengan OAE refer.
Kesimpulan : Terdapat hubungan bermakna antara 
penurunan pendengaran neonatus dengan kondisi 
preeklamsia ibu, yang ditentukan terutama oleh TDD ibu, 
serta berat lahir bayi.
Kata kunci : OAE, preeklamsia,tekanan darah usia reproduksi 
tidak hamil, vitamin D.
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INTRODUCTION
Severe preeclampsia (PE) is a complication that 
affects 2-7% of pregnancies and causing vascular 
damaged that lead to maternal multiple organ 
failure and severe hypoxic conditions to the fetus 
in utero.1
A study conducted in 2008 revealed that 33% 
of infants from mothers with a history of severe PE 
experience hearing loss shortly postpartum. Other 
studies have also mentioned that the hearing loss 
also arises in the fetus of the mother with severe 
PE.2This indicates that hypoxia itself gives such a 
considerable infl uence on the hearing loss.3
Hearing loss of newborns from the mothers 
with severe PE showed a decrease in low 
frequency (125-500 Hz) which resembling a 
cochlear pathology condition. Decrease of blood 
fl ow will cause a decrease in the microcirculation 
of the cochlea, causing damage to the cochlear 
function. Decreased of blood fl ow to the internal 
hearing organ (nucleus cochlear hypoxia, 
cochlear nerve hypoxia, or direct cochlear 
damage organ) is the key of the pathogenicity of 
the sensorineural type hearing loss in the mother 
with severe PE.4Cochlear itself is very sensitive, 
especially in the apical part, to microcirculation 
decrease. Therefore, PE condition gives a high 
risk of sensorineural hearing loss.5
Examination with otoacoustic-emissions (OAE) 
has the advantage of not require expert expertise 
and very economical to be used as a postnatal 
screening tool. Having a high sensitivity and 
specifi city (>90%) on peripheral hearing loss.5 
Thus, this study aims to analyze maternal PE 
relationship with the degree of newborn hearing 
loss with OAE.
METHODS
A cross-sectional study was conducted at the 
Obgyn Department and ENT Department of 
RSMH Palembang since December 2016 – July 
2017. The study sample was all newborns from 
mothers with severe PE who were treated in the 
Obgyn Departement of RSMH Palembang and 
fulfi l the inclusion and exclusion criteria. Samples 
were taken by consecutive sampling technique.
Samples were then classifi ed into PE group and 
normal (control) group. Matching was performed 
at the aspect of age, number of gravidity, and 
parity. Newborns sample will undergo a hearing 
function test with OAE by the ENT colleagues. 
The results of the examination will be presented 
in tabular form and analyzed with SPSS ver 17.0.
The data are presented descriptively in the 
form of 2x2 tables and then bivariate analysis 
with X2 test and unpaired T-test to assess the 
relationship between risk factor and the observed 
output based on signifi cance (p) 0.05 (95% CI). 
The tendency of risks factor to the outcome of 
neonatal hearing loss was assessed by odds ratio 
(OR).
RESULTS
Research has been conducted to assess the 
relationship between PE with newborn hearing loss 
examined with OAE. Forty eight-term neonates 
born, either vaginally or abdominally, form PE 
mother (11 PE and 37 severe PE). Normality test 
with the Shapiro Wilk test was obtained for all 
independent variable which resulted in a normal 
distribution (p> 0,05).
Sample Demographic Characteristics
The characteristics of maternal demography are 
shown in Table 1. The number of PE mothers 
was in the severe PE category (77.1%) and there 
was no signifi cant difference in demographic 
characteristics between the severe PE and PE 
groups (p>0.05). Both groups have similar 
patterns of demographic characteristics, where 
the majority mother give birth at the ideal age 
(20-35 years), take medication during pregnancy, 
do not consume herbs during pregnancy, have 
no infection during pregnancy, and all have no 
deafness or hearing loss family history. In terms 
of birth method, it was known that the majority of 
PE groups underwent normal labour (54.5%) while 
the majority of the severe PE group underwent a 
cesarean section (56.7%).
Table 1. Characteristics of Maternal & Neonatal Demographics Subject (N = 48)
Demographic 
Characteristic
Maternal Characteristic
Maternal age (years)
<20 
20-35
>35
Gestational age
>37 weeks
<37 weeks
Drugs during pregnancy
No
Yes
Herbs during pregnancy
No
Yes
Infection or fever during 
pregnancy
No
Yes
H/ deafness in family
No
Yes
Delivery mode
Normal
Vaginal operative
Cesarean section
Neonatal Characteristic
Birth weight (<2500 gr)
No
Yes
Neonatal infection
No
Yes
Hyperbilirubinemia
No
Yes
Asphyxia
No
Yes
Cephalic Trauma
No
Yes
Ear Malformation
No
Yes
APGAR Score
Normal
Abnormal
NICU admission
No
Yes
* Chi Square test, 95%CI, £ Signifi cancy cannot be evaluate
0.935
0.698
(0.718 – 0.672)
0.388
0.246
(0.146 – 0.346)
0.208
(0.228 – 0.198)
0.200
(0.221 – 0.196)
0.551
(0.561 – 0.540)
£
0.389
(0.409 – 0.369)
0.454  (-513.214 – 233.362)
0.153
(0.164 – 0.142)
£
£
0.339
(0.349 – 0.329)
£
£
0.513
(0.523-0.503)
£
1
26
10
30
7
7
30
23
14
35
2
37
0
15
1
21
31.19892 + 6.53128
37.1622 + 1.16699
0
9
2
7
4
4
7
9
2
10
1
11
0
6
1
4
31.3636 + 4,80151
36.8182 + 1.07872
0
25.7
16.7
18,9
36.4
36.4
18.5
28.1
12.5
22.2
33.3
22.9
0
28.6
50
16.0
7
4
11
0
11
0
11
0
11
0
11
0
2
9
11
0
31.3636 + 4,80151
18.4
40
22.9
0
22.9
0
25
0
22.9
0
22.9
0
28.57
2
22.9
0
31
6
37
0
37
0
33
4
37
0
37
0
5
32
37
0
2908.11 + 565.380
81.6
60
77.1
0
77.1
0
75
100
77.1
0
77.1
0
71.43
78
77.1
0
100
74.3
83.3
81.1
63.6
63.6
81.8
71.9
87.5
77.8
66.7
77.1
0
71.4
50
84
PE Severe PE
n n% %
P- value
Table 1 also showed no signifi cant difference in 
neonates born from PE and severe PE groups. 
Nevertheless, there was asphyxia (n = 4) occurred 
in neonates born from severe PE mothers, but 
the absence of neonates treated in the NICU 
showed that asphyxia was mild and transient. The 
absence of this neonate characteristic difference 
indicates that severe PE and PE conditions do not 
signifi cantly infl uence the neonatal outcomes.
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Relationship of Neonates OAE with 
Preeclampsia
Table 2 indicates there is no signifi cant relationship 
between the degree of PE with the occurrence of 
neonatal hearing loss on both ears. So it can be 
deduced that the degree of PE does not affect 
the incidence of hearing loss in newborns based 
Neonates Hearing Loss Risk Factors
Table 3 showed that only maternal risk factors for 
DBP (cut off point 106 mmHg) were signifi cantly 
associated with neonatal OAE abnormalities, 
while other maternal risk factors were not 
signifi cant (p> 0.250), so multivariate analysis 
was not performed. Similarly, the risk factors for 
neonatal shows only birth weight (<2500 grams) 
which signifi cantly associated with neonates OAE 
abnormalities, while other risk factor were not 
signifi cant (p> 0.250) and multivariate analysis 
was not performed.
on OAE examination. However, the analysis of 
X2which uses the category data has a huge bias, 
mainly due to small sample sizes. So the analysis 
continued on the relationship of SBP and DBP to 
the occurrence of OAE abnormalities, as well as 
multivariate analysis to determine the signifi cant 
risk factors of OAE abnormalities based on 
maternal and neonatal variables.
Table 2. Neonates OAE Relationship with Preeclampsia and Blood Pressure (N = 48)
Table 3. Bivariate Analysis of Maternal and Neonatal Risk Factors for Abnormal OAE (N = 48)
* Fisher exact test, 95% CI,  § Independent T Test, 95% CI
Risk Factor
Risk Factor P-value
Severe PE
PE
Sistole (mean+SD)
Interval (min-max)
Diastole (mean+SD)
Interval (min-max) 
Total
OAE Dxt P-value
Refer
10 (83.3)
2 (16.7)
167.5+14.22
(150-200)
111.67+ 11.146
(100-140)
12 (100)
27 (75)
9 (25)
158. 61+10.185
(140-190)
101.11 + 7.848
(80-110)
36 (100)
0.437*
0.022§
0.001§
Pass
OAE Sin P-value
Refer
11 (84.6)
2 (15.4)
166.92+13.775
(150-200)
111.54+10.682
(100-140)
13 (100)
26 (74,3)
9 (25,7)
158.57+10.331
(140-190)
100.86+7.811
(80-110)
35 (100)
0.368*
0.028§
<0.001§
Pass
Maternal Risk Factor
Maternal age
>35 years
<35 yeas
Sistolic blood pressure
>160 mmHg
<160 mmHg
Diastolic blood pressure
>106 mmHg
<106 mmHg
Degree of PE
Severe PE
PE
Infection during pregnancy
Infection (+)
Infection (-)
Drug consumption
Yes
No
Herb consumption
Yes
No
History of Deafness in family
History (+)
History (-)
Mode of Delivery
Cesarean Section
Vaginal delivery
6 (46.2)
7 (53.8)
11 (84.6)
2 (15.4)
10 (76.9)
3 (23,1)
11 (84.6)
2 (15.4)
1 (7.7)
12 (92.3)
10 (76.9)
3 (23.1)
6 (46.2)
7 (53.8)
0 (0)
13 (100)
7 (53.8)
6 (46.2)
10 (28.6)
25 (71.4)
26 (74.3)
9 (25.7)
11 (31.4)
24 (68.6)
26 (74.3)
9 (25.7)
2 (5.7)
33 (94.3)
27 (77.1)
8 (22.9)
10 (28.6)
25 (71.4)
0 (0)
13 (100)
18 (51.4)
17 (48.6)
0.310
0.702
0.008
0.702
0.999
0.999
0.310
£
0.999
OAE
Refer Pass
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DISCUSSION
In addition to the fetomaternal circulation, 
severe PE affects uteroplacental perfusion due 
to vasospasm. Systemic vascular insuffi ciency, 
especially the placenta, will interfere with the 
developmental process of fetus (hypoxic fetus). 
Hypoxia leads to hyperpolarization of inner hair 
cells that can resulting in changes in hearing 
neurons.5
Spontaneous release of the auditory neuron 
is the result of spontaneous release of the 
transmitter by hair cells. The stimulation of sound 
will cause depolarization of hair cells that will lead 
to increased release of chemical transmitters and 
neural jumps. In fetal hypoxia, hyperpolarization 
of hair cells will result in a decrease in the number 
of transmitters released and result in a decrease 
in nerve activity.5
Based on maternal demographic characteristics 
analysis no infl uence of maternal age, history of 
drug consumption, herbal medicine, infection 
during pregnancy and delivery method to 
neonatal hearing loss (p> 0.05). These fi ndings 
are similar who examined maternal and placental 
factors for congenital hearing loss, suggesting 
that only funisitis (cord infection) was signifi cantly 
associated with neonatal hearing loss (p = 
0.05). While maternal age, parity, gestational 
age, delivery mode, use of antenatal drugs, 
and chorioamnionitis infection were statistically 
unrelated to neonatal hearing loss (p> 0.05).6 
The condition of funisitis was not investigated 
in this study, although funisitis appears to be a 
signifi cant factor for congenital hearing loss.
Increase in interleukin-6 (IL-6) in umbilical 
cord blood, signalling a signifi cant reduction 
in congenital hearing examined in neonates.7 
It was concluded that prenatal exposure to 
infl ammation could damage the inner ear organ 
when a fetal infl ammatory response occurs. On 
the other hand, the fi ndings of chorioamnionitis 
did not signifi cantly cause hearing impairment, so 
it is hypothesized that chorioamnionitis may not 
necessarily trigger a fetal infl ammatory response, 
the outbreak of this response being confi rmed 
only when there is an infl ammatory cytokine on 
the umbilical cord.6
In some literatures, the age of preterm and low 
birthweight (LBW) are reportedly important facts 
or risks for congenital hearing loss.7-9 A similar 
fi nding was found in this study, where birth 
weight <2.500 grams was signifi cantly affected 
by congenital hearing loss diagnosed as "refer" 
to OAE examination. This fi nding is logical given 
that LBW conditions can be caused by premature 
gestational age so that the maturation of the 
inner ear organ has not been fully achieved, or 
in the case of term, the LBW condition indicates 
placental insuffi ciency and chronic fetal hypoxia 
occurring in preeclampsia resulting in deep hair 
cell hyperpolarization which may result changes 
in hearing neurons fetus.5
A contradictory fi nding was found in 
Apgar score variables, in which no signifi cant 
association of Apgar scorewith congenital 
hearing loss was in contrast to previous studies. 
It has been hypothesized by previous studies 
that premature and  LBW babies are associated 
with low Apgar score, so low Apgar score(which 
indicate fetal hypoxia) are also signifi cantly 
associated with fetal hearing loss. However, 
this hypothesis is denied,where they found no 
signifi cant relationship between Apgar scoreof 1 
and 5 minutes with congenital hearing loss. It is 
hypothesized that Apgar score merely describe 
the condition of fetal well-being soon after birth 
and can not fully represent the intrauterine fetal 
hypoxia condition.6,10 So that it can be understood 
when the LBW baby can have a hearing loss even 
though their Apgar score was good. Another 
Neonatal Risk Factor
Birth weight (g)
> 2.500 
< 2.500 
APGAR score
10
< 10
Asphyxia
Asphyxia (+)
Asphyxia (-)
Fisher exact test, p = 0.05
7 (53.8)
6 (46.2)
3(23.1)
10 (76.9)
1 (7.7)
12 (92.3)
31 (88.6)
4 (11.4)
4 (11.4)
31 (88.6)
3 (8.6)
32 (91,4)
0.016
0.370
0.999
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consideration of no signifi cant association 
between Apgar values and hearing loss in this 
study was that Apgar values were assessed by 
different Pediatric residents so that the examiner 
bias could have an effect, and the Apgar 10 and 
<10 score categories resulted in inequality in 
assessments where the majority of neonates who 
were fi t more often rated Apgar 9 instead of 10.
The next important variable in the study was 
drug use during pregnancy, where no signifi cant 
association was found between the use of drugs 
during pregnancy with congenital hearing loss. 
The study did not specify what medications were 
used during pregnancy, so no analysis of the 
effects of each type of drug could be performed. 
In 2017, stated that prenatal antibiotic use has 
no effect on congenital hearing loss, and on the 
contrary, the use of corticosteroids has a positive 
effect which decreases congenital hearing loss in 
premature fetuses.6
The main maternal variable in this study was 
maternal blood pressure with a diagnosis of 
preeclampsia. In this study, it was found that 
blood pressure, especially diastolic with a cut 
off of 106 mmHg, was signifi cantly associated 
with congenital hearing loss, while systolic blood 
pressure with a cut off of 160 mmHg was not 
signifi cantly related. These fi ndings are similar 
to those who found a signifi cant association 
between maternal blood pressure and congenital 
hearing loss, wherein the hearing impaired fetus 
was mainly from the maternal group with a mean 
systolic blood pressure of 156 ± 9.8 mm Hg (p 
<0.001) and diastolic blood pressure of 103.7 + 
4.9 mmHg (p <0.001).11
Not many studies have described maternal 
blood pressure and compared women with normal 
preeclampsia with fi ndings that differ from this 
study. For example, that there is no difference in 
neonatal hearing loss outcomes of the maternal 
group with hypertension in pregnancy and normal 
maternal groups;12Result and hypothesized that 
congenital hearing loss is caused by multifactorial 
factors, particularly environmental and genetic 
factors. Altuntas, however, found that women with 
HELLP syndrome were signifi cantly associated 
with congenital sensorineural hearing loss.2These 
contradictory fi ndings indicate that relationships 
between maternal blood pressure and congenital 
hearing loss need to be further investigated and 
use more detailed and comprehensive designs 
and tools.
Neonatal variables in this study found no 
signifi cant association with congenital hearing 
loss, except birth weight. The same is also who 
states that perinatal characteristics of fetal age 
at delivery, birth weight, fetal sex, Apgar score, 
umbilical arterial pH, and postnatal neonatal 
decline (e.g. RDS, broncho-pulmonary dysplasia, 
intraventricular haemorrhage, periventricular 
leukomalacia, necrotizing enterocolitis, and 
seizures) are not associated with congenital 
hearing loss.6
This study was conducted on samples of PE 
mothers categorized as PE and severe PE; not 
much research has studied the effects of maternal 
preeclampsia on the outcome of hearing loss in 
neonates. Nevertheless, the authors acknowledge 
that this study has many shortcomings, among 
others: the number of samples is too small 
to be representative did not include normal 
mothers without PE as a comparison used cross 
sectionaldesign so it could not be known whether 
the hearing loss in some neonates is reversible or 
irreversible; used simple tool which was OAE that 
only gives the result of "refer" or "pass" without 
any translation of hertz level which is a problem 
in neonate hearing; didn’t perform an analysis 
of the placenta using anatomical pathology 
examination to fi nd out whether chorioamnionitis 
and funicitis were risk factors; didn’t elaborate 
fully on research variables, for example drugs 
and herbs, types of prenatal infections, types of 
neonatal infections, Apgar score minutes 1, 5, 
and 10, and RDS types occured in neonates.
Further studies use prospective cohort 
design, larger sample size, healthy maternal as 
control, as well as advanced examination tools 
such as anatomic pathology, brainstem evoked 
response audiometry (BERA) ortransient evoked 
otoacoustic emission (TEOAE). Therefore, it is 
expected to provide more complete, informative, 
and valid relationships.
CONCLUSIONS
We noted that there was a signifi cant association 
between neonatal hearing loss and maternal 
PE, determined primarily by maternal DBP, and 
neonatal birth weight.
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